To make life easier for people with a common bladder condition, Medtronic is digging in far away from urinary tract.

For the first time, a device for releasing local chemotherapy in the bladder has been approved in the U.S., for patients who do not respond to standard treatment.

In July 2025, the FDA granted priority review for TAR-200 as therapy for patients with high-risk nonmuscle invasive bladder ...